Skip to main content

Cancer Organoids Multiplexed Screening in Microfluidic Textile chips

Project description

A new era in drug screening

Despite being at its infancy, microfluidics has the potential to become a widespread technology with numerous biomedical applications. The EU-funded COMMiT project proposes to exploit microfluidics for the high-throughput screening of large panels of drugs. Using the proprietary "free-flow textile chips" (FFTC) technology, scientists have the potential to produce 3D cell spheroids encapsulated within nanolitre droplets from a single tumour biopsy. The microfluidics platform can be employed to produce cell-based personalised models, replacing animal testing. The FFTC technology is expected to aid drug development in the pharmaceutical industry and support precision medicine.

Field of science

  • /engineering and technology/materials engineering/textiles
  • /medical and health sciences/clinical medicine/oncology/cancer

Call for proposal

ERC-2019-PoC
See other projects for this call

Funding Scheme

ERC-POC-LS - ERC Proof of Concept Lump Sum Pilot

Host institution

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Address
Rue Michel Ange 3
75794 Paris
France
Activity type
Research Organisations
EU contribution
€ 150 000

Beneficiaries (1)

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
France
EU contribution
€ 150 000
Address
Rue Michel Ange 3
75794 Paris
Activity type
Research Organisations